Safety and efficacy of 177Lu-PSMA-I&T Radioligand Therapy in Octogenarians with metastatic castration-resistant prostate cancer: Report on eighty patients over age eighty

Autor: Grigorascu, S., Tauber, R., Knorr, K., Retz, M., Rauscher, I., Hansen, K., D’Alessandria, C., Wester, H. J., Gschwend, J., Weber, W. A., Eiber, M., Langbein, T.
Zdroj: Nuklearmedizin. Nuclear medicine; April 2023, Vol. 62 Issue: 2
Databáze: Supplemental Index